Multiple myeloma: an immunologic profile. II. Bone marrow studies.

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Multiple myeloma is a cancer of plasma cells.
• Bone marrow immune cell populations are altered in multiple myeloma.
• Understanding these alterations is crucial for disease pathogenesis.

Purpose of the Study:

• To investigate bone marrow mononuclear cell populations in multiple myeloma patients.
• To compare immune cell characteristics between multiple myeloma, benign monoclonal gammopathy, and healthy controls.
• To assess the functional suppressive capacity of bone marrow cells on peripheral blood lymphocytes.

Main Methods:

• Analysis of bone marrow mononuclear cell populations.
• Measurement of cell receptors (complement, sheep red blood cell).
• Assessment of responses to mitogens (pokeweed, concanavalin A) and allogeneic stimuli.
• In vitro suppression assays on peripheral blood lymphocytes (PBLs).

Main Results:

• Untreated multiple myeloma patients showed increased complement receptor-bearing cells and mitogen responses.
• Treated multiple myeloma patients had higher sheep red blood cell receptor-bearing cells.
• Bone marrow cells from multiple myeloma patients suppressed PBL responses to plasma cells and allogeneic stimuli.
• Complement receptor-bearing cells inhibited pokeweed mitogen responses.

Conclusions:

• Bone marrow immune cell populations exhibit distinct characteristics in multiple myeloma.
• Specific bone marrow cell populations possess immunosuppressive functions.
• These immunosuppressive lymphocytes may play a role in the pathogenesis of multiple myeloma.